Logo image of USNA

USANA HEALTH SCIENCES INC (USNA) Stock Fundamental Analysis

NYSE:USNA - New York Stock Exchange, Inc. - US90328M1071 - Common Stock - Currency: USD

29.42  -0.64 (-2.13%)

After market: 29.42 0 (0%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to USNA. USNA was compared to 35 industry peers in the Personal Care Products industry. USNA is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. USNA has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year USNA was profitable.
USNA had a positive operating cash flow in the past year.
Each year in the past 5 years USNA has been profitable.
Each year in the past 5 years USNA had a positive operating cash flow.
USNA Yearly Net Income VS EBIT VS OCF VS FCFUSNA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

1.2 Ratios

USNA has a Return On Assets of 4.67%. This is in the better half of the industry: USNA outperforms 68.57% of its industry peers.
Looking at the Return On Equity, with a value of 6.59%, USNA is in the better half of the industry, outperforming 74.29% of the companies in the same industry.
USNA has a Return On Invested Capital (5.52%) which is in line with its industry peers.
The Average Return On Invested Capital over the past 3 years for USNA is significantly below the industry average of 16.32%.
The last Return On Invested Capital (5.52%) for USNA is well below the 3 year average (10.32%), which needs to be investigated, but indicates that USNA had better years and this may not be a problem.
Industry RankSector Rank
ROA 4.67%
ROE 6.59%
ROIC 5.52%
ROA(3y)9.11%
ROA(5y)13.39%
ROE(3y)12.23%
ROE(5y)18.88%
ROIC(3y)10.32%
ROIC(5y)15.36%
USNA Yearly ROA, ROE, ROICUSNA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

Looking at the Profit Margin, with a value of 3.98%, USNA is in the better half of the industry, outperforming 68.57% of the companies in the same industry.
In the last couple of years the Profit Margin of USNA has declined.
USNA has a Operating Margin (6.54%) which is in line with its industry peers.
USNA's Operating Margin has declined in the last couple of years.
The Gross Margin of USNA (80.53%) is better than 100.00% of its industry peers.
In the last couple of years the Gross Margin of USNA has remained more or less at the same level.
Industry RankSector Rank
OM 6.54%
PM (TTM) 3.98%
GM 80.53%
OM growth 3Y-18.51%
OM growth 5Y-10.85%
PM growth 3Y-20.58%
PM growth 5Y-12.29%
GM growth 3Y-0.21%
GM growth 5Y-0.29%
USNA Yearly Profit, Operating, Gross MarginsUSNA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), USNA is creating some value.
The number of shares outstanding for USNA has been reduced compared to 1 year ago.
The number of shares outstanding for USNA has been reduced compared to 5 years ago.
Compared to 1 year ago, USNA has a worse debt to assets ratio.
USNA Yearly Shares OutstandingUSNA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
USNA Yearly Total Debt VS Total AssetsUSNA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

An Altman-Z score of 4.07 indicates that USNA is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 4.07, USNA is doing good in the industry, outperforming 62.86% of the companies in the same industry.
There is no outstanding debt for USNA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 4.07
ROIC/WACC0.62
WACC8.97%
USNA Yearly LT Debt VS Equity VS FCFUSNA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

USNA has a Current Ratio of 2.05. This indicates that USNA is financially healthy and has no problem in meeting its short term obligations.
USNA has a Current ratio of 2.05. This is in the better half of the industry: USNA outperforms 62.86% of its industry peers.
USNA has a Quick Ratio of 1.51. This is a normal value and indicates that USNA is financially healthy and should not expect problems in meeting its short term obligations.
USNA has a better Quick ratio (1.51) than 68.57% of its industry peers.
Industry RankSector Rank
Current Ratio 2.05
Quick Ratio 1.51
USNA Yearly Current Assets VS Current LiabilitesUSNA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

4

3. Growth

3.1 Past

The earnings per share for USNA have decreased strongly by -23.05% in the last year.
USNA shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -10.07% yearly.
USNA shows a decrease in Revenue. In the last year, the revenue decreased by -2.69%.
The Revenue has been decreasing by -4.23% on average over the past years.
EPS 1Y (TTM)-23.05%
EPS 3Y-23.07%
EPS 5Y-10.07%
EPS Q2Q%-15.12%
Revenue 1Y (TTM)-2.69%
Revenue growth 3Y-10.36%
Revenue growth 5Y-4.23%
Sales Q2Q%9.54%

3.2 Future

The Earnings Per Share is expected to grow by 15.32% on average over the next years. This is quite good.
Based on estimates for the next years, USNA will show a quite strong growth in Revenue. The Revenue will grow by 9.38% on average per year.
EPS Next Y2.39%
EPS Next 2Y15.32%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year11.44%
Revenue Next 2Y9.38%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
USNA Yearly Revenue VS EstimatesUSNA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M 1B
USNA Yearly EPS VS EstimatesUSNA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2 4 6

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 11.91, the valuation of USNA can be described as very reasonable.
USNA's Price/Earnings ratio is rather cheap when compared to the industry. USNA is cheaper than 82.86% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 25.82. USNA is valued rather cheaply when compared to this.
USNA is valuated reasonably with a Price/Forward Earnings ratio of 8.51.
Based on the Price/Forward Earnings ratio, USNA is valued cheaply inside the industry as 94.29% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 21.76. USNA is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 11.91
Fwd PE 8.51
USNA Price Earnings VS Forward Price EarningsUSNA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of USNA indicates a rather cheap valuation: USNA is cheaper than 88.57% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 5.08
USNA Per share dataUSNA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of USNA may justify a higher PE ratio.
USNA's earnings are expected to grow with 15.32% in the coming years. This may justify a more expensive valuation.
PEG (NY)4.98
PEG (5Y)N/A
EPS Next 2Y15.32%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

USNA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

USANA HEALTH SCIENCES INC

NYSE:USNA (5/23/2025, 9:01:22 PM)

After market: 29.42 0 (0%)

29.42

-0.64 (-2.13%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)04-22 2025-04-22/amc
Earnings (Next)07-21 2025-07-21/amc
Inst Owners58.43%
Inst Owner Change0.31%
Ins Owners0.74%
Ins Owner Change0.29%
Market Cap547.80M
Analysts43.33
Price Target62.22 (111.49%)
Short Float %8.41%
Short Ratio3.89
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.21%
Min EPS beat(2)2.24%
Max EPS beat(2)28.18%
EPS beat(4)3
Avg EPS beat(4)6.24%
Min EPS beat(4)-18.68%
Max EPS beat(4)28.18%
EPS beat(8)6
Avg EPS beat(8)16.14%
EPS beat(12)8
Avg EPS beat(12)17.2%
EPS beat(16)10
Avg EPS beat(16)12.1%
Revenue beat(2)2
Avg Revenue beat(2)0.47%
Min Revenue beat(2)0.28%
Max Revenue beat(2)0.66%
Revenue beat(4)2
Avg Revenue beat(4)-2.31%
Min Revenue beat(4)-5.56%
Max Revenue beat(4)0.66%
Revenue beat(8)4
Avg Revenue beat(8)-1.6%
Revenue beat(12)6
Avg Revenue beat(12)-0.96%
Revenue beat(16)8
Avg Revenue beat(16)-0.96%
PT rev (1m)0%
PT rev (3m)18.45%
EPS NQ rev (1m)-10%
EPS NQ rev (3m)-19.4%
EPS NY rev (1m)-5.09%
EPS NY rev (3m)-4.4%
Revenue NQ rev (1m)-3.12%
Revenue NQ rev (3m)-3.54%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.26%
Valuation
Industry RankSector Rank
PE 11.91
Fwd PE 8.51
P/S 0.63
P/FCF N/A
P/OCF 9.32
P/B 1.03
P/tB 2.3
EV/EBITDA 5.08
EPS(TTM)2.47
EY8.4%
EPS(NY)3.46
Fwd EY11.75%
FCF(TTM)-8.28
FCFYN/A
OCF(TTM)3.16
OCFY10.73%
SpS47.06
BVpS28.45
TBVpS12.8
PEG (NY)4.98
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.67%
ROE 6.59%
ROCE 9.41%
ROIC 5.52%
ROICexc 7.83%
ROICexgc 24.33%
OM 6.54%
PM (TTM) 3.98%
GM 80.53%
FCFM N/A
ROA(3y)9.11%
ROA(5y)13.39%
ROE(3y)12.23%
ROE(5y)18.88%
ROIC(3y)10.32%
ROIC(5y)15.36%
ROICexc(3y)25.77%
ROICexc(5y)39.61%
ROICexgc(3y)41.63%
ROICexgc(5y)58.84%
ROCE(3y)17.59%
ROCE(5y)26.19%
ROICexcg growth 3Y-27.3%
ROICexcg growth 5Y-19.15%
ROICexc growth 3Y-45.52%
ROICexc growth 5Y-31.11%
OM growth 3Y-18.51%
OM growth 5Y-10.85%
PM growth 3Y-20.58%
PM growth 5Y-12.29%
GM growth 3Y-0.21%
GM growth 5Y-0.29%
F-Score5
Asset Turnover1.17
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 1080.18%
Cap/Sales 24.31%
Interest Coverage 551.17
Cash Conversion 76.31%
Profit Quality N/A
Current Ratio 2.05
Quick Ratio 1.51
Altman-Z 4.07
F-Score5
WACC8.97%
ROIC/WACC0.62
Cap/Depr(3y)569.36%
Cap/Depr(5y)383.35%
Cap/Sales(3y)9.41%
Cap/Sales(5y)6.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-23.05%
EPS 3Y-23.07%
EPS 5Y-10.07%
EPS Q2Q%-15.12%
EPS Next Y2.39%
EPS Next 2Y15.32%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.69%
Revenue growth 3Y-10.36%
Revenue growth 5Y-4.23%
Sales Q2Q%9.54%
Revenue Next Year11.44%
Revenue Next 2Y9.38%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-36.93%
EBIT growth 3Y-26.96%
EBIT growth 5Y-14.62%
EBIT Next Year54.93%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-293.26%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-39.39%
OCF growth 3Y-20.46%
OCF growth 5Y-13.6%